Selinexor Maintenance Post CAR-T Cell Therapy
Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 20 patients (estimated)
- Sponsors
- Washington University School of Medicine
- Collaborators
- Karyopharm Therapeutics
- Tags
- Post-CAR T, Maintenance, High Risk
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 2184
- NCT Identifier
- NCT07200102
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.